#1 Clinical Trials Search in Europe

Still’s disease – Diagnostics

Go back

Still’s disease is a rare inflammatory condition that requires careful evaluation to distinguish it from other illnesses with similar symptoms, as there is no single test that can confirm the diagnosis on its own.

Introduction: Who Should Seek Diagnostic Testing

If you experience a high fever that repeatedly spikes to at least 102 degrees Fahrenheit (38.9 degrees Celsius), along with a salmon-colored rash and achy joints, it’s important to see your healthcare provider. These symptoms may appear suddenly and can easily be mistaken for common illnesses like the flu or a viral infection. However, if these symptoms persist for more than two or three weeks without improvement, you should become more concerned and seek medical evaluation.[1][2]

Adults between the ages of 16 and 35 are most commonly affected by adult-onset Still’s disease, though it can occur at any age. The condition typically shows two peak periods: one between ages 15 and 25, and another between ages 36 and 45. Because the early symptoms often resemble many other common conditions, including infections, autoimmune diseases, or even certain cancers like lymphoma, proper diagnostic evaluation becomes essential to rule out these other possibilities.[3][4]

You should also seek immediate medical attention if you already have adult Still’s disease and develop new or worsening symptoms. Early recognition and diagnosis are particularly important because Still’s disease can lead to serious complications if left untreated, including joint damage (especially in the wrists), inflammation of the heart or lungs, liver problems, and a life-threatening condition called macrophage activation syndrome.[4][7]

⚠️ Important
Still’s disease is one of the main reasons for hospital admissions due to fever of unknown origin. Because it is rare, many doctors may not be familiar with it, which can delay diagnosis. If your symptoms don’t improve or worsen over several weeks despite treatment for common illnesses, ask your doctor to consider less common conditions like Still’s disease.

Classic Diagnostic Methods

Diagnosing adult Still’s disease presents a significant challenge because there is no single laboratory test or imaging study that can definitively confirm the condition. Instead, diagnosis relies on a process of exclusion, where doctors systematically rule out other diseases that cause similar symptoms. This approach requires patience and thoroughness, as the symptoms of Still’s disease can mimic many other conditions, including infections, other types of arthritis, autoimmune diseases, and even certain cancers.[4][6]

The diagnostic process typically begins with a comprehensive review of your symptoms, medical history, and a detailed physical examination. Your doctor will look for the characteristic triad of Still’s disease: high spiking fevers, a distinctive salmon-pink rash that appears and disappears with fever spikes, and joint pain or inflammation. The fever pattern is particularly notable—it usually spikes once or twice daily, often in the morning and evening, and can persist for a week or longer.[1][6]

Blood tests play a central role in the diagnostic workup, though not to confirm Still’s disease directly, but rather to rule out other conditions and identify patterns consistent with inflammation. Common blood tests include a complete blood count, which often shows elevated white blood cells (particularly neutrophils, a type of white blood cell), and tests for inflammatory markers such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), which are typically elevated during active disease.[8][13]

One of the most important laboratory findings in Still’s disease is an extremely elevated level of ferritin, a protein that stores iron in the body. Ferritin levels frequently exceed 1000 nanograms per milliliter (ng/ml), and this marked elevation is considered a distinguishing feature of the condition. While high ferritin can occur in other inflammatory conditions, the degree of elevation seen in Still’s disease is often dramatically higher.[3][4]

Doctors will also perform blood tests to rule out other conditions. Tests for rheumatoid factor (RF) and anti-nuclear antibody (ANA) are typically negative in Still’s disease, which helps distinguish it from rheumatoid arthritis and lupus. Additional blood work may include liver function tests, as Still’s disease can affect the liver, and throat cultures or tests for specific infections that might cause similar symptoms.[6][8]

Imaging tests are used to assess the extent of joint involvement and rule out other causes of symptoms. X-rays may be performed to check for joint inflammation or damage, particularly in the wrists, which are commonly affected in Still’s disease. Early in the disease, X-rays may appear normal, but over time, chronic inflammation can lead to visible joint damage. Other imaging studies, such as ultrasound, CT scans, or echocardiograms, may be ordered if there is concern about involvement of internal organs like the heart, lungs, liver, or spleen.[8][13]

Because Still’s disease can affect multiple organ systems, your doctor may examine you for enlarged lymph nodes, particularly in the neck, and may check for enlargement of the liver or spleen through physical examination or imaging. The characteristic rash, when present, typically appears on the trunk, arms, or legs and has a distinctive appearance—it’s salmon-pink in color and often comes and goes with fever spikes, which is an important diagnostic clue.[1][2]

The most widely accepted diagnostic criteria are the Yamaguchi criteria, which require at least five features of the disease to be present, with at least two being major criteria. Major criteria include fever of at least 39 degrees Celsius for at least one week, joint pain or arthritis lasting at least two weeks, a characteristic rash, and elevated white blood cell count with neutrophil predominance. Minor criteria include sore throat, lymph node enlargement, liver or spleen enlargement, abnormal liver function tests, and negative tests for RF and ANA.[5]

Diagnostics for Clinical Trial Qualification

When patients with Still’s disease are being considered for enrollment in clinical trials, they typically undergo a standardized set of diagnostic tests to confirm their diagnosis and assess the severity of their condition. These assessments ensure that participants meet specific inclusion criteria and help researchers understand the baseline characteristics of each patient before any experimental treatment begins.[9]

Clinical trials for Still’s disease generally require documented evidence of diagnosis based on established criteria, most commonly the Yamaguchi criteria. Potential participants must show proof of the characteristic clinical features, including documented fever patterns, the presence of the typical rash, and evidence of arthritis or joint pain lasting the required duration. This documentation often includes medical records from previous healthcare visits and photographs of the rash if available.[5]

Laboratory testing is essential for trial qualification. Blood work typically includes measurement of inflammatory markers such as ESR and CRP to establish baseline inflammation levels. Ferritin levels are measured, as many trials specifically enroll patients with markedly elevated ferritin. A complete blood count documents white blood cell counts and checks for other blood abnormalities. Liver function tests are performed because Still’s disease can affect the liver, and some trial medications may also impact liver function, making baseline measurements crucial.[3][9]

Serological tests to exclude other conditions are standard in trial screening. Tests for RF and ANA must be negative or only mildly positive, as strongly positive results might suggest a different autoimmune condition. Additional screening may include tests for infectious diseases such as hepatitis, HIV, and tuberculosis, as active infections are typically exclusion criteria for trials involving immunosuppressive medications.[6]

Imaging studies form another component of baseline assessment in clinical trials. X-rays of affected joints, particularly the wrists and knees, document the extent of joint involvement and any existing damage. Some trials may require more advanced imaging such as MRI or ultrasound to provide detailed information about inflammation in joints and soft tissues. If there is any concern about organ involvement, additional imaging of the chest (to evaluate the heart and lungs) or abdomen (to assess the liver and spleen) may be required.[8]

Disease activity scoring is often used in clinical trials to quantify how active a patient’s Still’s disease is at the time of enrollment. This helps researchers understand whether participants have mild, moderate, or severe disease, and allows for measurement of improvement during the trial. Various scoring systems may assess the number of active joints, the severity of fever, the presence and extent of rash, and laboratory markers of inflammation.[9]

Patients entering clinical trials may also undergo assessment for potential complications of Still’s disease. This can include echocardiography to check heart function, pulmonary function tests to assess lung capacity, and detailed liver imaging or testing if there are concerns about liver involvement. These baseline assessments help identify patients who might be at higher risk during the trial and provide comparison points for monitoring safety throughout the study.[7]

⚠️ Important
Clinical trials for Still’s disease may require multiple visits for diagnostic testing before enrollment can be confirmed. This thorough screening process protects patient safety and ensures that only appropriate candidates participate. If you’re interested in clinical trials, discuss with your doctor whether your current diagnostic tests are sufficient or if additional assessments would be needed.

Prognosis and Survival Rate

Prognosis

The prognosis for Still’s disease varies considerably depending on which pattern the condition follows in each individual patient. Adult-onset Still’s disease typically manifests in one of three main patterns, and understanding which pattern you have can help predict your long-term outlook. About one-third of patients experience what doctors call a monophasic pattern, meaning they have a single episode of symptoms that lasts weeks to months but typically resolves within a year. These individuals often experience complete resolution of symptoms and may not require long-term treatment.[2][4]

Another third of patients follow a polyphasic or intermittent pattern, where they experience multiple episodes of symptoms separated by periods of remission that can last weeks to years. The episodes tend to become shorter and less severe over time. The remaining third of patients develop chronic Still’s disease, characterized by persistent symptoms or regular flares. This chronic form is more likely to cause progressive joint damage similar to what occurs in rheumatoid arthritis, particularly affecting the wrists. It’s important to note that sometimes what initially appears to be monophasic or polyphasic Still’s disease can later evolve into the chronic form, making long-term prognosis difficult to predict early in the disease course.[2][4]

Several factors can affect prognosis and the likelihood of complications. Patients who develop chronic arthritis are at higher risk for permanent joint damage and disability. Life-threatening complications, though rare, can occur and include macrophage activation syndrome (a severe immune system overreaction), heart inflammation (pericarditis or myocarditis), lung problems (pleuritis or interstitial lung disease), and rarely, amyloidosis, where abnormal protein deposits affect organ function. Early diagnosis and appropriate treatment significantly improve outcomes by controlling inflammation and preventing these serious complications.[4][7]

With modern treatment approaches, including anti-inflammatory medications, corticosteroids, and newer biologic therapies that target specific inflammatory molecules, many patients can achieve good disease control and maintain a reasonable quality of life. However, the unpredictable nature of the disease means that patients must often adapt their expectations about daily activities and long-term plans, learning to manage around flares when they occur.[8]

Survival rate

While specific survival statistics for Still’s disease are not extensively documented in the provided sources, the condition is generally not considered immediately life-threatening for most patients. The disease itself does not typically cause death directly. However, serious complications can occur, particularly if the disease is not diagnosed promptly or treated adequately. The most dangerous complication is macrophage activation syndrome, which requires immediate medical intervention and can be life-threatening if not treated quickly.[4]

Other potentially serious complications include severe inflammation of the heart muscle or the sac surrounding the heart, significant lung involvement, and liver damage. These complications, while uncommon, underscore the importance of regular monitoring and maintaining good disease control. Patients with chronic Still’s disease who develop persistent joint inflammation may experience significant disability from joint damage, though this affects quality of life rather than survival. With appropriate medical care and monitoring for complications, most patients with Still’s disease can expect a normal or near-normal lifespan.[4][7]

Ongoing Clinical Trials on Still’s disease

  • A Study of MAS825 in Children and Adults with Still’s Disease to Test How Well It Works and How Safe It Is

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain

  • Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

References

https://www.mayoclinic.org/diseases-conditions/adult-stills-disease/symptoms-causes/syc-20351907

https://my.clevelandclinic.org/health/diseases/adult-onset-stills-disease-aosd

https://www.ncbi.nlm.nih.gov/books/NBK538345/

https://www.sobi.com/en/stills-disease

https://en.wikipedia.org/wiki/Adult-onset_Still%27s_disease

https://www.arthritis.org/diseases/adult-stills-disease

https://www.hss.edu/health-library/conditions-and-treatments/list/adult-onset-stills-disease

https://www.mayoclinic.org/diseases-conditions/adult-stills-disease/diagnosis-treatment/drc-20351912

https://pmc.ncbi.nlm.nih.gov/articles/PMC11147545/

More information about
Still’s disease:

FAQ

Is there a specific blood test that can diagnose Still’s disease?

No, there is no single blood test that can definitively diagnose Still’s disease. Diagnosis requires a combination of clinical symptoms, physical examination findings, and multiple blood tests that together create a picture consistent with Still’s disease while ruling out other conditions. The dramatically elevated ferritin level is one of the strongest laboratory clues, but it must be interpreted along with other findings.

How long does it typically take to get diagnosed with Still’s disease?

The time to diagnosis varies considerably, but because Still’s disease is rare and its symptoms mimic many common conditions, diagnosis can be delayed for weeks or even months. Many patients are initially treated for viral infections or other conditions before Still’s disease is suspected. The diagnosis process involves systematically excluding other possibilities, which naturally takes time.

What makes Still’s disease difficult to diagnose?

Several factors make diagnosis challenging: the disease is extremely rare, so many doctors have limited experience with it; the symptoms closely resemble common illnesses like flu or viral infections; there’s no definitive diagnostic test; and the condition must be diagnosed by excluding many other diseases. Additionally, the characteristic rash and fever pattern may not always be present when the patient visits the doctor.

What are the Yamaguchi criteria used for diagnosing Still’s disease?

The Yamaguchi criteria are the most widely accepted diagnostic guidelines for Still’s disease. They require at least five features to be present, with at least two being major criteria. Major criteria include high fever for at least one week, joint pain lasting at least two weeks, the characteristic rash, and elevated white blood cells. Minor criteria include sore throat, swollen lymph nodes or enlarged organs, abnormal liver tests, and negative tests for rheumatoid factor and ANA.

Do I need to see a specialist for Still’s disease diagnosis?

While your primary care doctor may initially evaluate your symptoms, you will likely need to see a rheumatologist (a specialist in arthritis and autoimmune diseases) for definitive diagnosis and treatment of Still’s disease. Because the condition is rare and complex, rheumatologists have more experience recognizing the pattern of symptoms and managing the diagnostic workup.

🎯 Key takeaways

  • • Still’s disease has no single definitive test—diagnosis relies on recognizing a pattern of symptoms while systematically ruling out other conditions that look similar.
  • • Extremely elevated ferritin levels (often exceeding 1000 ng/ml) serve as one of the strongest laboratory clues for Still’s disease, though high ferritin alone cannot confirm the diagnosis.
  • • The characteristic “Still’s triad” of high spiking fevers, salmon-pink rash, and joint pain forms the foundation of diagnosis, but all three features may not always be present simultaneously.
  • • Tests for rheumatoid factor and anti-nuclear antibodies are typically negative in Still’s disease, which helps distinguish it from other autoimmune conditions like rheumatoid arthritis and lupus.
  • • The Yamaguchi criteria, requiring at least five features with two being major criteria, provide the most widely accepted framework for diagnosing Still’s disease.
  • • If fever, rash, and joint pain persist for more than two to three weeks without improvement, it’s essential to seek medical evaluation rather than assuming it’s just a common viral illness.
  • • Clinical trial enrollment for Still’s disease requires extensive baseline testing including blood work, imaging studies, disease activity scoring, and screening for complications to ensure patient safety.
  • • Early diagnosis matters significantly because untreated Still’s disease can lead to serious complications including permanent joint damage, heart inflammation, lung problems, and life-threatening macrophage activation syndrome.

Connected medications: